FDA.reportPublic FDA data

Ameluz 10 % Topical Gel

RxCUI
1806650
RxNorm name
Ameluz 10 % Topical Gel
Display name
Ameluz 10 % Topical Gel
Full name
Ameluz 10 % Topical Gel
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
650daa9f-aeec-49ce-95b9-5fa20b988afdAmeluz 10 % Topical Gel [PSN] · aminolevulinic acid hydrochloride 0.1 MG/MG Topical Gel [Ameluz] [SBD] · Ameluz 0.1 MG/MG Topical Gel [SY] · Ameluz 10 % Topical Gel [SY]431These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 199920251222